Early signs of myocardial systolic dysfunction in patients with type 2 diabetes are strongly associated with myocardial microvascular dysfunction independent of myocardial fibrosis: a prospective cohort study

被引:1
|
作者
Bojer, Annemie S. [1 ,3 ]
Sorensen, Martin H. [1 ]
Madsen, Stine H. [3 ]
Broadbent, David A. [4 ,5 ]
Plein, Sven [5 ]
Gaede, Peter [1 ,2 ]
Madsen, Per L. [3 ,6 ]
机构
[1] Slagelse Hosp, Dept Cardiol & Endocrinol, Ingemannsvej 32, DK-4200 Slagelse, Region Zealand, Denmark
[2] Univ Southern Denmark, Fac Hlth Sci, Inst Reg Hlth Res, Odense, Denmark
[3] Copenhagen Univ Hosp Herlev Gentofte, Dept Cardiol, Herlev, Denmark
[4] Leeds Teaching Hosp NHS Trust, Dept Med Phys & Engn, Leeds, England
[5] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, England
[6] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
来源
DIABETOLOGY & METABOLIC SYNDROME | 2024年 / 16卷 / 01期
关键词
Type; 2; diabetes; Cardiovascular complications; Global longitudinal strain; Cardiovascular magnetic resonance imaging; Myocardial microvascular function; Myocardial extracellular volume; GLOBAL LONGITUDINAL STRAIN; MAGNETIC-RESONANCE; HEART-FAILURE; RESERVE;
D O I
10.1186/s13098-024-01285-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with diabetes demonstrate early left ventricular systolic dysfunction. Notably reduced global longitudinal strain (GLS) is related to poor outcomes, the underlying pathophysiology is however still not clearly understood. We hypothesized that pathophysiologic changes with microvascular dysfunction and interstitial fibrosis contribute to reduced strain. Methods 211 patients with type 2 diabetes and 25 control subjects underwent comprehensive cardiovascular phenotyping by magnetic resonance imaging. Myocardial blood flow (MBF), perfusion reserve (MPR), extracellular volume (ECV), and 3D feature tracking GLS and global circumferential (GCS) and radial strain (GRS) were quantified. Results Patients (median age 57 [IQR 50, 67] years, 70% males) had a median diabetes duration of 12 [IQR 6, 18] years. Compared to control subjects GLS, GCS, and GRS were reduced in the total diabetes cohort, and GLS was also reduced in the sub-group of patients without diabetic complications compared to control subjects (controls - 13.9 +/- 2.0%, total cohort - 11.6 +/- 3.0%; subgroup - 12.3 +/- 2.6%, all p < 0.05). Reduced GLS, but not GCS or GRS, was associated with classic diabetes complications of albuminuria (UACR >= 30 mg/g) [beta (95% CI) 1.09 (0.22-1.96)] and autonomic neuropathy [beta (95% CI) 1.43 (0.54-2.31)] but GLS was not associated with retinopathy or peripheral neuropathy. Independently of ECV, a 10% increase in MBF at stress and MPR was associated with higher GLS [multivariable regression adjusted for age, sex, hypertension, smoking, and ECV: MBF stress (beta (95% CI) - 0.2 (- 0.3 to - 0.08), MPR (beta (95% CI) - 0.5 (- 0.8 to - 0.3), p < 0.001 for both]. A 10% increase in ECV was associated with a decrease in GLS in univariable [beta (95% CI) 0.6 (0.2 to 1.1)] and multivariable regression, but this was abolished when adjusted for MPR [multivariable regression adjusted for age, sex, hypertension, smoking, and MPR (beta (95% CI) 0.1 (- 0.3 to 0.6)]. On the receiver operating characteristics curve, GLS showed a moderate ability to discriminate a significantly lowered stress MBF (AUC 0.72) and MPR (AUC 0.73). Conclusions Myocardial microvascular dysfunction was independent of ECV, a biomarker of myocardial fibrosis, associated with GLS. Further, 3D GLS could be a potential screening tool for myocardial microvascular dysfunction. Future directions should focus on confirming these results in longitudinal and/or interventional studies.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Early signs of myocardial systolic dysfunction in patients with type 2 diabetes are strongly associated with myocardial microvascular dysfunction independent of myocardial fibrosis: a prospective cohort study
    Annemie S. Bojer
    Martin H. Sørensen
    Stine H. Madsen
    David A. Broadbent
    Sven Plein
    Peter Gæde
    Per L. Madsen
    Diabetology & Metabolic Syndrome, 16
  • [2] Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis in Patients with Type 2 Diabetes Using Quantitative Perfusion MRI
    Bernard, Monique
    Kober, Frank
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024, 60 (06) : 2407 - 2408
  • [3] MYOCARDIAL DYSFUNCTION AND METABOLIC DERANGEMENT IN TYPE 2 DIABETES: RELATIONSHIP WITH PROCOLLAGEN BIOMARKERS OF MYOCARDIAL FIBROSIS
    Jellis, Christine L.
    Sacre, Julian W.
    Haluska, Brian
    Jenkins, Carly
    Marwick, Thomas H.
    Martin, Jennifer H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E860 - E860
  • [4] BIOMARKERS OF MYOCARDIAL FIBROSIS AND RENAL DYSFUNCTION IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bilovol, Oleksandr M.
    Kniazkova, Iryna I.
    Kirienko, Oleksandr M.
    Bogun, Maryna, V
    Kirienko, Denis M.
    Abramova, Lilya P.
    Berezin, Alexander E.
    PHARMACOPHORE, 2020, 11 (06): : 132 - 140
  • [5] Subclinical hepatic fibrosis is associated with coronary microvascular dysfunction by myocardial perfusion reserve index: a retrospective cohort study
    Kwan, Alan C.
    Wei, Janet
    Lee, Brian P.
    Luong, Eric
    Salto, Gerran
    Nguyen, Trevor-Trung
    Botting, Patrick G.
    Liu, Yunxian
    Ouyang, David
    Ebinger, Joseph E.
    Li, Debiao
    Noureddin, Mazen
    Thomson, Louise
    Berman, Daniel S.
    Merz, C. Noel Bairey
    Cheng, Susan
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2022, 38 (07): : 1579 - 1586
  • [6] Gender and myocardial fibrosis by CMR are independent predictors of myocardial dysfunction in patients with Chagas' heart disease
    Antonildes N Assunção
    Bernardo B Lopes
    Alejandra Villanueva
    Liliane Rocha
    Carolina S Reiser
    Eduardo B Falchetto
    Simone Cristina S Costa
    Barbara Ianni
    Fabio Fernandes
    Marly U Lopes
    Roberto Kalil
    Carlos E Rochitte
    Journal of Cardiovascular Magnetic Resonance, 17 (Suppl 1)
  • [7] Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus
    Rijzewijk, Luuk J.
    van der Meer, Rutger W.
    Smit, Johannes W. A.
    Diamant, Michaela
    Bax, Jeroen J.
    Hammer, Sebastiaan
    Romijn, Johannes A.
    de Roos, Albert
    Lamb, Hildo J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (22) : 1793 - 1799
  • [8] Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus
    van der Meer, R. W.
    Rijzewijk, L. J.
    Diamant, M.
    Bax, J. J.
    Romijn, J. A.
    Smit, J. W. A.
    de Roos, A.
    Lamb, H. J.
    DIABETOLOGIA, 2008, 51 : S53 - S53
  • [9] Relationship of pro-collagen biomarkers of myocardial fibrosis with myocardial dysfunction and metabolic derangement in type 2 diabetes
    Jellis, C.
    Sacre, J.
    Jenkins, C.
    Haluska, B.
    Martin, J.
    Marwick, T.
    EUROPEAN HEART JOURNAL, 2012, 33 : 933 - 933
  • [10] RELATIONSHIP BETWEEN CORONARY MICROVASCULAR DYSFUNCTION, MYOCARDIAL OXYGENATION AND ABNORMAL MYOCARDIAL ENERGETICS AT REST AND STRESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Levelt, Eylem
    Holloway, Cameron
    Rodgers, Christopher
    Clarke, William
    Mahmod, Masliza
    Ariga, Rina
    Francis, Jane
    Liu, Alexander
    Robson, Matthew
    Clarke, Kieran
    Karamitsos, Theodoros
    Neubauer, Stefan
    HEART, 2015, 101 : A69 - A70